Cargando…

Peripapillary Choroidal Neovascularization Associated with Optic Nerve Head Drusen Treated with Anti-VEGF Agents

Optic nerve head drusen can be associated with peripapillary choroidal neovascularization, in both the pediatric and adult population. These membranes can involve the macula, causing significant visual loss. Herein, we present a case that required treatment with an anti-VEGF agent. The patient faile...

Descripción completa

Detalles Bibliográficos
Autores principales: Saffra, Norman A., Reinherz, Benjamin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357672/
https://www.ncbi.nlm.nih.gov/pubmed/25802505
http://dx.doi.org/10.1159/000375480
_version_ 1782361176733122560
author Saffra, Norman A.
Reinherz, Benjamin J.
author_facet Saffra, Norman A.
Reinherz, Benjamin J.
author_sort Saffra, Norman A.
collection PubMed
description Optic nerve head drusen can be associated with peripapillary choroidal neovascularization, in both the pediatric and adult population. These membranes can involve the macula, causing significant visual loss. Herein, we present a case that required treatment with an anti-VEGF agent. The patient failed to respond to the initial agent, but subsequently responded to a change of agent. Adult patients with macular degeneration involving peripapillary choroidal neovascularization associated with optic nerve head drusen may require individualized treatment plans.
format Online
Article
Text
id pubmed-4357672
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-43576722015-03-23 Peripapillary Choroidal Neovascularization Associated with Optic Nerve Head Drusen Treated with Anti-VEGF Agents Saffra, Norman A. Reinherz, Benjamin J. Case Rep Ophthalmol Published online: February, 2015 Optic nerve head drusen can be associated with peripapillary choroidal neovascularization, in both the pediatric and adult population. These membranes can involve the macula, causing significant visual loss. Herein, we present a case that required treatment with an anti-VEGF agent. The patient failed to respond to the initial agent, but subsequently responded to a change of agent. Adult patients with macular degeneration involving peripapillary choroidal neovascularization associated with optic nerve head drusen may require individualized treatment plans. S. Karger AG 2015-02-10 /pmc/articles/PMC4357672/ /pubmed/25802505 http://dx.doi.org/10.1159/000375480 Text en Copyright © 2015 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published online: February, 2015
Saffra, Norman A.
Reinherz, Benjamin J.
Peripapillary Choroidal Neovascularization Associated with Optic Nerve Head Drusen Treated with Anti-VEGF Agents
title Peripapillary Choroidal Neovascularization Associated with Optic Nerve Head Drusen Treated with Anti-VEGF Agents
title_full Peripapillary Choroidal Neovascularization Associated with Optic Nerve Head Drusen Treated with Anti-VEGF Agents
title_fullStr Peripapillary Choroidal Neovascularization Associated with Optic Nerve Head Drusen Treated with Anti-VEGF Agents
title_full_unstemmed Peripapillary Choroidal Neovascularization Associated with Optic Nerve Head Drusen Treated with Anti-VEGF Agents
title_short Peripapillary Choroidal Neovascularization Associated with Optic Nerve Head Drusen Treated with Anti-VEGF Agents
title_sort peripapillary choroidal neovascularization associated with optic nerve head drusen treated with anti-vegf agents
topic Published online: February, 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357672/
https://www.ncbi.nlm.nih.gov/pubmed/25802505
http://dx.doi.org/10.1159/000375480
work_keys_str_mv AT saffranormana peripapillarychoroidalneovascularizationassociatedwithopticnerveheaddrusentreatedwithantivegfagents
AT reinherzbenjaminj peripapillarychoroidalneovascularizationassociatedwithopticnerveheaddrusentreatedwithantivegfagents